Skip to main content
S. 1367 117th Congress Senate

United States Pharmaceutical Supply Chain Review Act

Official title: A bill to require a report on foreign investment in the pharmaceutical industry of the United States.

Introduced: April 26, 2021 Introduced by: Elizabeth Warren Democratic · Massachusetts See on congress.gov
Health Congressional oversightGeneticsGovernment information and archivesGovernment studies and investigations
More subjectsShow fewer subjects
Health technology, devices, suppliesIndustrial policy and productivityManufacturingPrescription drugsRetail and wholesale tradesU.S. and foreign investments
Sign in to write a letter Sign in to watch
This bill died when the 117th Congress ended
It never became law before the 117th Congress (2021–2022) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 26, 2021
Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
Apr 26, 2021
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action April 26, 2021

Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.

 Plain-English summary Congressional Research Service

United States Pharmaceutical Supply Chain Review Act

This bill requires the Federal Trade Commission to submit annually to Congress a report on foreign investment in the U.S. pharmaceutical industry. The report shall address, among other topics, the effect of the industry's reliance on foreign manufacturing.

 Related & companion bills 1
  • S 1366 Pharmaceutical Supply Chain Defense and Enhancement Act
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
Cite this page click to expand
APA
U.S. Congress. (2026). S. 1367: United States Pharmaceutical Supply Chain Review Act. 117th Congress. Open America. https://openamerica.io/bill/117-S-1367/
MLA
"S. 1367: United States Pharmaceutical Supply Chain Review Act." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-S-1367/.
Bluebook (legal)
S. 1367, 117th Cong. (2026), https://openamerica.io/bill/117-S-1367/.
Markdown link
[S. 1367: United States Pharmaceutical Supply Chain Review Act](https://openamerica.io/bill/117-S-1367/)
Report a problem